๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Measuring the cost-effectiveness of hematopoietic growth factor therapy

โœ Scribed by Rebecca S. Finley

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
358 KB
Volume
67
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Estrogen replacement therapy modulation
Estrogen replacement therapy modulation of the insulin-like growth factor system in monkey knee joints
โœ Janet K. Fernihough; Renee S. Richmond; Cathy S. Carlson; Tom Cherpes; Jeffrey M ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 149 KB

Objective. Epidemiologic studies have suggested that estrogen replacement therapy may lower the risk of osteoarthritis in women, but the mechanism of this effect is unknown. Since estrogen acts in other tissues in part through regulation of the insulin-like growth factor (IGF) system as well as cyto

Use of the Dowell Bryant Incontinence Co
Use of the Dowell Bryant Incontinence Cost Index as a post-treatment outcome measure after non-surgical therapy
โœ A.M. Simons; C.J. Dowell; C.M. Bryant; S. Prashar; K.H. Moore ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 77 KB ๐Ÿ‘ 1 views

The aim of this study was to use the previously validated Dowell Bryant Incontinence Cost Index (DBICI) as a post-treatment outcome measure after non-surgical therapy and to determine whether the magnitude of reduced leakage would correlate with the magnitude of reduced personal cost. A simple ureth